AYTU Aytu BioPharma, Inc. - Common Stock
$2,35
Preço · Ago 18, 2026
Fundamentais a partir de Mai 13, 2026
Intervalo 52 Semanas
$2–$3
49% of range
Classificação do Analista
BUY
9 analysts
Preço-Alvo
$10
+304% upside
P/E (TTM)
-3.3
ROE
-54.5%
Margem de Lucro Líquido
-20.4%
AYTU Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$2.35
Capitalização de Mercado
$21M
P/E (TTM)
-3.3
EPS (TTM)
—
Receita (TTM)
$66M
Rendimento div.
—
ROE
-54.5%
Dívida/Capital
0.7
Intervalo 52 Semanas
$2 – $3
AYTU Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$66M
2016-06-30
→
2025-06-30
EPS
—
2021-06-30
→
2023-06-30
Fluxo de caixa livre
$-2M
2016-06-30
→
2025-06-30
Margens
-20.4%
2022-06-30
→
2025-06-30
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
AYTU
Mediana de Pares
P/E (TTM)
-3.3
53.4
P/S (TTM)
0.3
11.1
P/B
1.1
1.3
EV / EBITDA
-1.2
—
Price / FCF (Preço / FCF)
-9.7
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
AYTU
Mediana de Pares
Gross Margin (Margem Bruta)
69.0%
73.8%
Operating Margin (Margem Operacional)
-11.8%
—
Net Profit Margin (Margem de Lucro Líquido)
-20.4%
-24.7%
ROA
-11.2%
-30.6%
ROE
-54.5%
-56.4%
ROIC
-25.5%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
AYTU
Mediana de Pares
Debt / Equity (Dívida / Patrimônio Líquido)
0.7
0.0
Current Ratio (Índice de liquidez corrente)
1.3
1.6
Quick Ratio (Índice de Liquidez Seca)
1.0
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
AYTU
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
1.8%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-11.8%
—
Revenue CAGR 5Y (CAGR Receita 5A)
19.2%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
AYTU
Mediana de Pares
AYTU Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
9 analistas
- Compra forte 2 22,2%
- Compra 6 66,7%
- Manter 1 11,1%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
3 analistas · 2026-08-17
Mediana
$7.00
Média
$9.50
← Abaixo de todos os alvos
$2.35
Mín
$7.00
Máx
$14.50
Alvo mediano
$7.00
+197,9%
Alvo médio
$9.50
+304,3%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-0.50%
Próximo relatório
Set 21, 2026
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Setembro de 2026 | $-0.53 | $-0.33 | — |
| 31 de Março de 2026 | $-0.53 | $-0.52 | -0.01% |
| 31 de Dezembro de 2025 | $-1.05 | $-0.61 | -0.44% |
| 30 de Setembro de 2025 | $0.21 | $-0.23 | 0.44% |
| 30 de Junho de 2025 | $-2.92 | $-0.04 | -2.9% |
| 31 de Março de 2025 | $0.21 | $-0.17 | 0.38% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| AYTU | $20M | -3.0 | 1.8% | -20.4% | -54.5% | 69.0% |
| MIRA | $63M | -1.1 | -40.3% | -10557.5% | -190.5% | — |
| TXMD | $19M | -32.6 | 71.6% | -18.8% | -2.1% | — |
| QCLS | — | -0.5 | — | — | — | — |
| CTXR | — | -0.4 | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $66M | $65M | $107M | $97M | $66M | $28M | $7M | $4M | $3M | $3M | $261.8K | · | |
| Cost of Revenue | $21M | $16M | $41M | $44M | $36M | $8M | $2M | $2M | $1M | $957.1K | $88.1K | · | |
| Gross Profit | $46M | $49M | $67M | $52M | $29M | $19M | · | · | · | · | · | · | |
| R&D Expense | $1M | $3M | $4M | $13M | $6M | $2M | $589.1K | $167.6K | $959.9K | $6M | $3M | · | |
| SG&A Expense | $17M | $20M | $29M | $31M | $26M | $20M | $19M | $18M | $17M | $9M | $4M | · | |
| Operating Expenses | $54M | $51M | $84M | $162M | $88M | $40M | $24M | $23M | $23M | $24M | $8M | · | |
| Operating Income | $-8M | $-2M | $-17M | $-110M | $-59M | $-21M | $-17M | $-20M | $-20M | $-22M | $-8M | · | |
| Interest Expense | · | · | · | · | · | $3M | $535.5K | $749.4K | $3M | $5M | $115.0K | · | |
| Other Non-op | $-512.0K | $870.0K | $184.0K | $-757.0K | $-2M | $-3M | $-10M | $4M | $-2M | $-6M | $-115.0K | · | |
| Pretax Income | $-14M | $-10M | $-17M | $-109M | $-58M | $-14M | · | · | · | $-28M | $-8M | · | |
| Income Tax | $437.0K | $2M | $0 | $-110.0K | $259.0K | $0 | $0 | $0 | · | $0 | $-23.9K | · | |
| Net Income | $-14M | $-16M | $-17M | $-109M | $-58M | $-14M | $-27M | $-10M | $-23M | $-28M | $-8M | $-61.7K | |
| EPS (Basic) | $-2.16 | $-2.86 | $-5.11 | $-74.01 | $-3.48 | · | · | · | · | · | · | · | |
| EPS (Diluted) | · | · | $-5.11 | $-74.01 | $-3.48 | · | · | · | · | · | · | · | |
| Shares (Basic) | 6,279,744 | 5,537,957 | 3,339,906 | 1,469,875 | 16,746,679 | · | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | 3,339,906 | 1,469,875 | 16,746,679 | · | · | · | · | · | · | · | |
| EBITDA | $-2M | $3M | $-8M | $-101M | · | $-15M | $-14M | $-17M | · | $-21M | $-8M | · |
Balanço Patrimonial 30
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $31M | $20M | $23M | $19M | $50M | $48M | $11M | $7M | $802.3K | $8M | $7M | $2.3K | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $1M | $0 | · | |
| Receivables | $31M | $24M | $29M | $22M | $28M | $6M | $2M | $578.8K | $528.0K | $162.4K | $157.1K | · | |
| Inventory | $11M | $12M | $12M | $11M | $16M | $10M | $1M | $1M | $1M | $524.7K | $39.4K | · | |
| Prepaid Expense | $6M | $5M | $7M | $7M | $10M | $6M | $957.8K | $440.0K | $310.8K | $215.6K | $370.9K | $171 | |
| Other Current Assets | · | $62M | $71M | $633.0K | $1M | $6M | $0 | · | · | · | · | · | |
| Current Assets | $79M | $62M | $73M | $60M | $105M | $75M | $15M | $9M | $3M | $10M | $8M | $2.5K | |
| PP&E (Net) | $532.0K | $693.0K | $2M | · | · | $258.5K | $203.7K | $218.7K | $647.3K | $231.4K | $29.7K | $2.7K | |
| PP&E (Gross) | $1M | $3M | $5M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $714.0K | $2M | $4M | · | · | $484.0K | $396.0K | $540.0K | $246.0K | $112.0K | $60.0K | · | |
| Goodwill | · | · | $0 | $0 | $66M | $28M | $0 | · | $238.4K | $221.0K | $74.0K | · | |
| Intangibles | $42M | $52M | $59M | $71M | $85M | $49M | $49M | $245.9K | $271.3K | $296.6K | $628.8K | · | |
| Other Non-current Assets | $1M | $2M | $3M | $766.0K | $465.0K | $33.0K | $19M | $11M | $9M | $11M | $0 | · | |
| Total Assets | $124M | $118M | $136M | $138M | $266M | $153M | $35M | $21M | $15M | $24M | $18M | $5.5K | |
| Accounts Payable | $11M | $10M | $13M | · | $19M | $12M | $2M | $2M | $2M | $2M | $1M | $310 | |
| Accrued Liabilities | $38M | $38M | $47M | $44M | $57M | $9M | $1M | $185.9K | $782.5K | $1M | · | $1.6K | |
| Short-term Debt | · | $2M | $2M | $4M | · | $982.1K | $0 | · | · | · | · | · | |
| Current Liabilities | $63M | $62M | $69M | $64M | $109M | $29M | $5M | $3M | $4M | $10M | $1M | $50.5K | |
| Capital Leases | $985.0K | $577.0K | $832.0K | $2M | $3M | $725.0K | $0 | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $41.4K | · | |
| Other Non-current Liabilities | $5M | $5M | $7M | $13M | $18M | $11.0K | $0 | · | · | · | · | · | |
| Total Liabilities | · | · | $97M | $93M | $128M | $58M | $28M | $8M | $11M | $14M | $3M | · | |
| Long-term Debt | $13M | $13M | $15M | $15M | · | · | $0 | $0 | · | · | · | · | |
| Total Debt | $13M | $15M | $2M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $4.0K | $3.0K | $1.0K | $1.8K | $179 | $4 | $19 | $119 | $539.7K | |
| Paid-in Capital | $352M | $348M | $343M | · | $316M | $215M | $113M | $93M | $73M | · | · | · | |
| Retained Earnings | $-334M | $-320M | $-304M | $-287M | $-178M | $-120M | $-106M | $-79M | $-69M | $-47M | $-18M | $-630.4K | |
| Stockholders' Equity | $19M | $28M | $39M | $44M | $138M | $95M | $7M | $13M | $4M | $10M | $16M | $-45.0K | |
| Liabilities + Equity | $124M | $118M | $136M | $138M | $266M | $153M | $35M | $21M | $15M | $24M | $18M | $5.5K | |
| Shares Outstanding | 8,976,913 | 5,972,638 | 5,517,174 | 1,928,941 | 27,490,412 | 12,583,736 | 17,538,071 | 1,794,762 | 41,244 | 187,098 | 1,188,307 | 5,735,402 |
Fluxo de Caixa 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $7M | $9M | $10M | $9M | $6M | $3M | $3M | $4M | $874.8K | $118.2K | · | |
| Stock-based Comp | $576.0K | $2M | $6M | $5M | $4M | $1M | $1M | $596.9K | $3M | $902.9K | $1M | · | |
| Deferred Tax | · | $0 | $-126.0K | $-117.0K | $243.0K | · | · | · | · | $0 | $-23.9K | · | |
| Amort. of Intangibles | $4M | $4M | $5M | $6M | $6M | $4M | $2M | $2M | $2M | $664.7K | $90.7K | · | |
| Restructuring | $2M | $2M | $0 | $0 | $5M | $667.0K | · | · | $1.5K | $0 | · | · | |
| Other Non-cash | $6M | $3M | $-3M | $66M | · | $-22M | $10M | $-9M | · | $16M | $-23.0K | · | |
| Operating Cash Flow | $-2M | $-1M | $-5M | $-29M | $-26M | $-28M | $-14M | $-16M | $-14M | $-11M | $-7M | · | |
| CapEx | $228.0K | $329.0K | · | $0 | $2M | $0 | $59.8K | $74.7K | $111.6K | $252.9K | $0 | · | |
| Investing Cash Flow | $-3M | $-329.0K | $-117.0K | $-3M | $-3M | $-6M | $-1M | $-484.3K | $-4M | · | · | · | |
| Debt Issued | $2M | $13M | · | · | · | $640.0K | $0 | $0 | · | · | · | · | |
| Net Debt Issued | $0 | $-16M | · | · | · | $640.0K | $5M | · | · | · | · | · | |
| Stock Issued | · | · | $16M | $12M | $45M | $66M | · | · | $739.9K | $0 | $0 | · | |
| Net Stock Activity | · | · | $16M | · | · | · | · | · | · | $8M | · | · | |
| Financing Cash Flow | $15M | $-1M | $9M | $2M | $30M | $71M | $19M | $23M | $10M | · | · | · | |
| Net Change in Cash | $11M | $-3M | $4M | $-31M | $2M | $37M | $4M | $6M | $-7M | $701.1K | $5M | · | |
| Taxes Paid | $1M | $2M | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-2M | · | · | $-29M | · | $-28M | $-14M | $-16M | · | $-11M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-16M | · | · |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.0% | 67.4% | 62.0% | 54.1% | · | · | · | · | · | · | · | · | |
| Operating Margin | -11.8% | -6.5% | -15.9% | -115.4% | · | -76.5% | -230.1% | -538.2% | · | -847.0% | -2915.5% | · | |
| Net Margin | -20.4% | -19.6% | -15.9% | -114.0% | · | -49.3% | -370.6% | -278.4% | · | -1099.7% | -2950.3% | · | |
| Pretax Margin | -20.7% | -17.4% | -15.9% | -114.1% | · | · | · | · | · | -1099.7% | -2959.4% | · | |
| EBITDA Margin | -3.7% | 3.7% | -7.7% | -104.8% | · | -53.9% | -192.9% | -467.4% | · | -812.9% | -2870.4% | · | |
| ROA | -11.2% | -12.4% | -12.4% | -54.6% | · | -14.5% | -97.3% | -56.5% | · | -132.5% | -84.7% | · | |
| ROE | -54.5% | -54.2% | -42.5% | -145.3% | · | -15.1% | -234.6% | -77.8% | · | -219.3% | -99.2% | · | |
| ROIC | -25.5% | -13.8% | -41.7% | -241.8% | · | · | · | · | · | -215.2% | -48.7% | · |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | · | 1.1 | 0.9 | · | 2.6 | 2.9 | 2.8 | · | 1.0 | 5.5 | · | |
| Quick Ratio | 1.0 | 0.7 | 0.8 | 0.6 | · | 1.9 | 2.4 | 2.2 | · | 0.9 | 5.1 | · | |
| Debt / Equity | 0.7 | 0.5 | 0.0 | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.4 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | -8.1 | -31.5 | -26.3 | · | -4.0 | · | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.8 | 0.5 | · | 0.3 | 0.3 | 0.2 | · | 0.1 | 0.0 | · | |
| Inventory Turnover | 1.7 | 2.1 | 3.6 | 3.3 | · | 1.3 | 1.6 | 1.5 | · | 3.4 | 4.5 | · | |
| Receivables Turnover | 2.4 | 3.1 | 4.2 | 3.9 | · | 8.0 | 6.3 | 6.6 | · | 16.0 | 3.3 | · |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1.8% | -39.3% | 11.1% | 47.3% | 137.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -11.8% | -0.23% | 57.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.2% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $66M | $65M | $107M | $97M | $66M | $28M | $7M | $4M | $3M | $3M | $261.8K | · | |
| Net Income TTM | $-14M | $-16M | $-17M | $-109M | $-58M | $-14M | $-27M | $-10M | $-23M | $-28M | $-8M | $-61.7K | |
| Market Cap | $20M | $17M | $9M | $532M | · | $35.74B | $6.63B | $1.87B | · | $1.40T | $5.20T | · | |
| Enterprise Value | $1M | $13M | $-13M | · | · | · | · | · | · | · | · | · | |
| P/E | -3.0 | -0.7 | -0.3 | -0.2 | -28.8 | · | · | · | · | · | · | · | |
| P/S | 0.3 | 0.3 | 0.1 | 5.5 | · | 1293.3 | 905.6 | 510.0 | · | 546737.1 | 19871235.0 | · | |
| P/B | 1.0 | 0.6 | 0.2 | 11.6 | · | 376.1 | 935.3 | 139.0 | · | 138914.1 | 333105.9 | · | |
| P / Tangible Book | · | · | · | · | · | 1977.7 | · | · | · | · | · | · | |
| P / Cash Flow | -10.1 | -12.6 | -1.7 | -18.5 | · | -1259.5 | -479.3 | -117.1 | · | -131455.8 | -784106.7 | · | |
| P / FCF | -9.0 | · | · | -18.5 | · | -1259.5 | -477.2 | -116.6 | · | -128408.3 | · | · | |
| EV / EBITDA | -0.6 | 4.2 | 1.5 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -0.6 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.0 | 0.2 | -0.1 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -33.0% | -136.0% | -319.4% | -536.3% | -3.5% | · | · | · | · | · | · | · |
Demonstração de Resultados 16
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | $15M | $14M | $15M | $18M | $16M | $17M | $15M | $14M | $19M | $18M | $31M | $23M | $26M | $28M | $27M | |
| Cost of Revenue | $5M | $6M | $5M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $12M | $10M | $9M | $10M | $13M | |
| Gross Profit | $8M | $10M | $9M | $10M | $13M | $11M | $12M | $11M | $10M | $15M | $13M | $19M | $13M | $17M | $18M | $15M | |
| R&D Expense | $0 | $0 | $0 | $216.0K | $162.0K | $522.0K | $426.0K | $1M | $611.0K | $521.0K | $595.0K | $465.0K | $856.0K | $2M | $1M | $3M | |
| SG&A Expense | $5M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $7M | $7M | |
| Operating Expenses | $12M | $12M | $11M | $18M | $10M | $12M | $13M | $13M | $12M | $11M | $14M | $18M | $21M | $24M | $20M | $32M | |
| Operating Income | $-4M | $-2M | $-2M | $-8M | $2M | $-2M | $-930.0K | $-2M | $-2M | $3M | $-867.0K | $169.0K | $-9M | $-7M | $-2M | $-17M | |
| Other Non-op | $149.0K | $190.0K | $201.0K | $-1M | $36.0K | $140.0K | $542.0K | $120.0K | $70.0K | $96.0K | $584.0K | $4M | $-1M | $-1M | $-1M | $-428.0K | |
| Pretax Income | $-6M | $-11M | $2M | $-19M | $4M | $382.0K | $1M | $-3M | $-2M | $1M | $-7M | $-2M | $-7M | $-7M | $-701.0K | $-16M | |
| Income Tax | $10.0K | $0 | $0 | $437.0K | $-122.0K | $-283.0K | $405.0K | $841.0K | $521.0K | $780.0K | $0 | $0 | $0 | $0 | · | $0 | |
| Net Income | $-6M | $-11M | $2M | $-20M | $4M | $788.0K | $1M | $-5M | $-3M | $-220.0K | $-8M | $-2M | $-7M | $-7M | $-701.0K | $-16M | |
| EPS (Basic) | $-0.53 | $-1.05 | $0.21 | $-3.18 | $0.65 | $0.13 | $0.24 | $-0.82 | $-0.52 | $-0.04 | $-1.48 | $-0.75 | $-1.93 | $-2.15 | $-0.28 | $-7.61 | |
| EPS (Diluted) | $-0.53 | $-1.05 | $-0.08 | · | $0.21 | $-0.26 | $-0.15 | · | $-0.52 | $-0.04 | $-1.48 | · | $-1.93 | $-2.15 | $-0.28 | $-7.61 | |
| Shares (Basic) | 10,511,583 | 10,036,359 | 9,441,073 | -12,054,969 | 6,134,634 | 6,132,060 | 6,068,019 | -10,995,305 | 5,533,555 | 5,517,670 | 5,482,037 | -6,015,083 | 3,726,779 | 3,110,304 | 2,517,906 | -2,615,105 | |
| Shares (Diluted) | 10,511,583 | 10,036,359 | 19,476,635 | · | 8,204,453 | 8,485,112 | 9,099,601 | · | 5,533,555 | 5,517,670 | 5,482,037 | · | 3,726,779 | 3,110,304 | 2,517,906 | -2,615,105 | |
| EBITDA | $-4M | $-2M | $-701.0K | · | $2M | $-2M | $-930.0K | · | $-2M | $2M | $726.0K | · | $-9M | $-7M | $675.0K | · |
Balanço Patrimonial 28
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $30M | $33M | $31M | $18M | $20M | $20M | $20M | $20M | $20M | $20M | $23M | $19M | $20M | $24M | $19M | |
| Receivables | $24M | $31M | $33M | $31M | $36M | $25M | $23M | $24M | $30M | $29M | $30M | $29M | $34M | $26M | $28M | $22M | |
| Inventory | $7M | $9M | $10M | $11M | $11M | $11M | $12M | $12M | $13M | $13M | $13M | $12M | $14M | $13M | $13M | $11M | |
| Prepaid Expense | $9M | $7M | $5M | $6M | $7M | $6M | $6M | $5M | $7M | $8M | $7M | $7M | $10M | $12M | $9M | $7M | |
| Other Current Assets | · | · | · | · | · | $63M | $61M | · | $1M | $1M | $749.0K | $71M | $1M | $624.0K | $785.0K | $633.0K | |
| Current Assets | $67M | $76M | $81M | $79M | $73M | · | · | $62M | $71M | $71M | $71M | · | $78M | $71M | $74M | $60M | |
| PP&E (Net) | $407.0K | $484.0K | $500.0K | $532.0K | $546.0K | $516.0K | $692.0K | $693.0K | $967.0K | $1M | · | $2M | · | · | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $3M | $3M | $4M | $4M | · | $5M | · | · | · | · | |
| Accum. Depreciation | $802.0K | $768.0K | $735.0K | $714.0K | $690.0K | $651.0K | $2M | $2M | $3M | $3M | · | $4M | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Intangibles | $42M | $44M | $41M | $42M | $49M | $50M | $51M | $52M | $54M | $56M | $57M | $59M | $63M | $65M | $69M | $71M | |
| Other Non-current Assets | $556.0K | $738.0K | $939.0K | $1M | $1M | $2M | $2M | $2M | $889.0K | $907.0K | $772.0K | $3M | $892.0K | $821.0K | $829.0K | $766.0K | |
| Total Assets | $112M | $122M | $125M | $124M | $124M | $116M | $116M | $118M | $129M | $131M | $133M | $136M | $147M | $141M | $150M | $138M | |
| Accounts Payable | $13M | $14M | $12M | $11M | $12M | $12M | $14M | $10M | $10M | $10M | · | $13M | · | · | · | · | |
| Accrued Liabilities | $34M | $40M | $37M | $38M | $42M | $39M | $34M | $38M | $44M | $43M | $41M | $47M | $50M | $41M | $41M | $44M | |
| Short-term Debt | · | · | · | · | · | $4M | $4M | · | $2M | $1M | $1M | $2M | $10M | $7M | · | $4M | |
| Current Liabilities | $60M | $66M | $66M | $63M | $71M | $64M | $61M | $62M | $84M | $64M | $65M | $69M | $85M | $67M | $73M | $64M | |
| Capital Leases | $919.0K | $973.0K | $1M | $985.0K | $1M | $1M | $1M | $577.0K | $783.0K | · | $1M | $832.0K | $1M | $1M | $2M | $2M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $8M | $7M | $8M | $10M | $9M | $13M | |
| Total Liabilities | · | · | · | · | · | · | · | · | · | · | $101M | · | $106M | $96M | $102M | $93M | |
| Long-term Debt | $11M | $12M | $12M | $13M | $11M | $12M | $12M | · | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | |
| Total Debt | $11M | $12M | $12M | · | $11M | $16M | $17M | · | $17M | $16M | $1M | · | $10M | $7M | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | $6.0K | · | |
| Paid-in Capital | $383M | $356M | $355M | $352M | $349M | $348M | $348M | $348M | $346M | $345M | · | $343M | · | · | · | · | |
| Retained Earnings | $-348M | $-342M | $-332M | $-334M | $-314M | $-318M | $-318M | $-320M | $-315M | $-312M | $-312M | $-304M | $-302M | $-294M | $-288M | $-287M | |
| Stockholders' Equity | $35M | $14M | $23M | $19M | $35M | $31M | $30M | $28M | $31M | $33M | $32M | $39M | $41M | $46M | $48M | $44M | |
| Liabilities + Equity | $112M | $122M | $125M | $124M | $124M | $116M | $116M | $118M | $129M | $131M | $133M | $136M | $147M | $141M | $150M | $138M | |
| Shares Outstanding | 10,733,208 | 10,733,208 | 9,911,913 | 8,976,913 | 6,170,162 | 6,169,681 | 6,149,202 | 5,972,638 | 5,567,909 | 5,567,347 | 5,530,235 | 5,517,174 | 3,779,513 | 3,383,145 | 3,121,471 | 1,928,941 |
Fluxo de Caixa 14
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $885.0K | $803.0K | $1M | $1M | $1M | $1M | $2M | $758.0K | $1M | $-3M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $148.0K | $283.0K | $114.0K | $113.0K | $139.0K | $151.0K | $173.0K | $-188.0K | $811.0K | $820.0K | $930.0K | $900.0K | $902.0K | $3M | $1M | $1M | |
| Amort. of Intangibles | $761.0K | $526.0K | $444.0K | $921.0K | $920.0K | $921.0K | $921.0K | $921.0K | $920.0K | $918.0K | $924.0K | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $1M | $784.0K | $2M | $244.0K | $0 | $0 | · | · | · | · | · | |
| Other Non-cash | · | · | $-4M | · | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Operating Cash Flow | $-4M | $4M | $-618.0K | $3M | $-6M | $3M | $-1M | $-788.0K | $-300.0K | $-135.0K | $89.0K | $9M | $-3M | $-2M | $-9M | $-7M | |
| CapEx | $0 | $17.0K | $0 | $17.0K | $69.0K | $6.0K | $136.0K | $329.0K | $0 | · | $0 | · | · | · | · | · | |
| Investing Cash Flow | $0 | $-17.0K | $0 | $-3M | $-69.0K | $145.0K | $381.0K | $-34.0K | $-45.0K | $-174.0K | $174.0K | $-155.0K | $1.0K | $-5.0K | $42.0K | $-41.0K | |
| Net Debt Issued | · | · | $-464.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Financing Cash Flow | $872.0K | $-6M | $2M | $13M | $4M | $-3M | $911.0K | $1M | $530.0K | $-126.0K | $126.0K | $-5M | $3M | $-2M | $14M | $-1M | |
| Net Change in Cash | $-3M | $-3M | $2M | $13M | $-2M | $290.0K | $102.0K | $246.0K | $231.0K | $-435.0K | $435.0K | $4M | $-322.0K | $-4M | $4M | $-8M | |
| Taxes Paid | $0 | $61.0K | $140.0K | $0 | $0 | $973.0K | $446.0K | $1M | $130.0K | · | $-186.0K | $0 | $0 | · | · | · | |
| Free Cash Flow | · | · | $-618.0K | · | · | · | · | · | · | · | · | · | · | · | · | · |
Lucratividade 8
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.2% | 63.5% | 66.1% | · | 69.4% | 66.5% | 72.3% | · | 65.0% | 70.7% | 66.9% | · | 56.1% | 65.8% | 65.2% | · | |
| Operating Margin | -32.8% | -13.0% | -10.8% | · | 13.1% | -10.4% | -5.6% | · | -13.7% | 10.3% | -6.8% | · | -37.6% | -25.9% | -6.0% | · | |
| Net Margin | -45.3% | -69.8% | 14.1% | · | 21.6% | 4.9% | 8.9% | · | -16.1% | -0.96% | -36.7% | · | -31.7% | -25.5% | · | · | |
| Pretax Margin | -45.2% | -69.8% | 14.1% | · | 20.7% | 2.4% | 9.0% | · | -14.7% | 2.6% | -36.7% | · | -31.7% | -25.5% | -2.5% | · | |
| EBITDA Margin | -32.8% | -13.0% | -5.1% | · | 13.1% | -10.4% | -5.6% | · | -13.7% | 10.3% | 3.3% | · | -37.6% | -25.9% | 2.4% | · | |
| ROA | -4.8% | -8.9% | 1.6% | · | 3.2% | 0.64% | 1.2% | · | -2.1% | -0.16% | -5.7% | · | -4.6% | -3.7% | · | · | |
| ROE | -16.0% | -47.1% | 7.4% | · | 12.2% | 2.5% | 4.8% | · | -8.1% | -0.56% | -20.2% | · | -14.1% | -8.8% | · | · | |
| ROIC | -8.8% | -7.6% | -4.2% | · | 5.4% | -6.3% | -1.5% | · | -5.7% | -1.8% | · | · | · | · | · | · |
Liquidez e Solvência 4
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.2 | 1.2 | · | 1.0 | · | · | · | 0.8 | 1.1 | 1.1 | · | 0.9 | 1.1 | 1.0 | · | |
| Quick Ratio | 0.9 | 0.9 | 1.0 | · | 0.8 | 0.7 | 0.7 | · | 0.6 | 0.8 | 0.8 | · | 0.6 | 0.7 | 0.7 | · | |
| Debt / Equity | 0.3 | 0.8 | 0.5 | · | 0.3 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.0 | · | 0.3 | 0.2 | · | · | |
| LT Debt / Equity | 0.3 | 0.7 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.0 | 0.5 | · | · | · | · | · | · |
Eficiência 3
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.5 | 0.6 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.7 | 0.6 | 0.7 | · | |
| Receivables Turnover | 0.4 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.8 | 0.8 | · | 0.7 | 1.1 | 1.1 | · |
Avaliação (TTM) 13
| Métrica | Tendência | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $60M | $64M | $65M | · | $65M | $66M | $67M | · | $73M | $86M | $94M | · | $101M | $101M | $97M | · | |
| Net Income TTM | $-10M | $-4M | $8M | · | $3M | $-845.0K | $-10M | · | $-18M | $-22M | $-23M | · | $-68M | $-72M | $-93M | · | |
| Market Cap | $29M | $28M | $19M | · | $7M | $10M | $14M | · | $17M | $16M | $15M | · | $8M | $13M | $12M | · | |
| Enterprise Value | $14M | $10M | $-2M | · | $623.2K | $6M | $11M | · | $14M | $12M | $-4M | · | $-309.9K | $784.0K | · | · | |
| P/E | -1.9 | -2.2 | -6.7 | · | -1.7 | -1.8 | -1.1 | · | -0.8 | -0.5 | -0.5 | · | -0.1 | -0.1 | -0.1 | · | |
| P/S | 0.5 | 0.4 | 0.3 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | |
| P/B | 0.8 | 2.0 | 0.8 | · | 0.2 | 0.3 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.2 | 0.3 | 0.2 | · | |
| P / Cash Flow | · | · | -30.2 | · | · | · | · | · | · | · | -70.8 | · | · | · | -1.3 | · | |
| P / FCF | · | · | -30.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | -3.4 | -4.9 | 2.4 | · | 0.3 | -3.5 | -11.7 | · | -5.6 | 5.2 | -5.3 | · | 0.0 | -0.1 | · | · | |
| EV / FCF | · | · | 2.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.2 | 0.2 | -0.0 | · | 0.0 | 0.1 | 0.2 | · | 0.2 | 0.1 | -0.0 | · | -0.0 | 0.0 | · | · | |
| Earnings Yield | -53.1% | -45.4% | -14.9% | · | -60.0% | -57.1% | -93.2% | · | -130.6% | -197.2% | -216.3% | · | -1797.3% | -1238.7% | -1754.7% | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Receita | $66M | $65M | $107M | $97M | $66M |
| Margem Bruta % | 69.0% | 67.4% | 62.0% | 54.1% | — |
| Margem Operacional % | -11.8% | -6.5% | -15.9% | -115.4% | — |
| Lucro líquido | $-14M | $-16M | $-17M | $-109M | $-58M |
| EPS Diluído | — | — | $-5.11 | $-74.01 | $-3.48 |
Balanço Patrimonial
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.7 | 0.5 | 0.0 | — | — |
| Índice de liquidez corrente | 1.3 | — | 1.1 | 0.9 | — |
| Índice de Liquidez Seca | 1.0 | 0.7 | 0.8 | 0.6 | — |
Fluxo de Caixa
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-2M | — | — | $-29M | — |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 43 declarantes · $8.5M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 5 (+1 vs trimestre anterior) | 2 (-1 vs trimestre anterior) | 11 (+2 vs trimestre anterior) | 5 (+1 vs trimestre anterior) | +240K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $2.336.646 | 1.086.812 | 27,64% | Ações |
| Stonepine Capital Management, LLC | $1.962.780 | 912.921 | 23,22% | Ações |
| AWM Investment Company, Inc. | $1.332.084 | 619.574 | 15,76% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $561.464 | 261.146 | 6,64% | Ações |
| CROWN ADVISORS MANAGEMENT, INC. | $430.000 | 200.000 | 5,09% | Ações |
| DIADEMA PARTNERS LP | $319.374 | 148.546 | 3,78% | Ações |
| TWO SIGMA INVESTMENTS, LP | $226.451 | 105.326 | 2,68% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $225.369 | 104.823 | 2,67% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $156.742 | 72.889 | 1,85% | Ações |
| VANGUARD GROUP INC | $122.325 | 47.048 | 1,45% | Ações |
| TWO SIGMA ADVISERS, LP | $110.500 | 42.500 | 1,31% | Ações |
| CITADEL ADVISORS LLC | $106.240 | 49.414 | 1,26% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $101.153 | 47.048 | 1,20% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $94.579 | 43.990 | 1,12% | Ações |
| Persistent Asset Partners Ltd | $81.666 | 37.984 | 0,97% | Ações |
| NORTHERN TRUST CORP | $55.214 | 25.681 | 0,65% | Ações |
| BELLEVUE ASSET MANAGEMENT, LLC | $53.777 | 25.013 | 0,64% | Ações |
| PERRITT CAPITAL MANAGEMENT INC | $52.000 | 20.000 | 0,62% | Ações |
| BlackRock, Inc. | $49.005 | 22.793 | 0,58% | Ações |
| XTX Topco Ltd | $46.044 | 21.416 | 0,54% | Ações |
| Daytona Street Capital LLC | $22.350 | 10.000 | 0,26% | Ações |
| Tower Research Capital LLC (TRC) | $4.799 | 2.232 | 0,06% | Ações |
| ROYAL BANK OF CANADA | $1.000 | 378 | 0,01% | Ações |
| OSAIC HOLDINGS, INC. | $991 | 462 | 0,01% | Ações |
| UBS Group AG | $559 | 260 | 0,01% | Ações |
| JPMORGAN CHASE & CO | $337 | 154 | 0,00% | Ações |
| MORGAN STANLEY | $269 | 125 | 0,00% | Ações |
| CIBC Private Wealth Group LLC | $156 | 83 | 0,00% | Ações |
| BARCLAYS PLC | $108 | 50 | 0,00% | Ações |
| GROUP ONE TRADING LLC | $80 | 37 | 0,00% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $49 | 23 | 0,00% | Ações |
| WELLS FARGO & COMPANY/MN | $26 | 12 | 0,00% | Ações |
| Rockefeller Capital Management L.P. | $22 | 10 | 0,00% | Ações |
| SBI Securities Co., Ltd. | $22 | 10 | 0,00% | Ações |
| Moser Wealth Advisors, LLC | $22 | 10 | 0,00% | Ações |
| ACADIAN ASSET MANAGEMENT LLC | $22 | 10.237 | 0,00% | Ações |
| Farther Finance Advisors, LLC | $9 | 4 | 0,00% | Ações |
| VISION FINANCIAL MARKETS LLC | $5 | 2 | 0,00% | Ações |
| Caitong International Asset Management Co., Ltd | $4 | 2 | 0,00% | Ações |
| Arax Advisory Partners | $4 | 2 | 0,00% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $2 | 1 | 0,00% | Ações |
| FNY Investment Advisers, LLC | $0 | 110 | 0,00% | Ações |
| TSFG, LLC | $0 | 1 | 0,00% | Ações |
Executivos da empresa 16 insiders · 9 diretores · 7 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Joshua R. Disbrow | Chief Executive Officer | 28 de Julho de 2026 A | 237.203 | 0 | 0 | $0 |
| Ryan J Selhorn | Chief Financial Officer | 28 de Julho de 2026 A | 74.743 | 0 | 0 | $0 |
| Mark K Oki | Chief Financial Officer | 11 de Agosto de 2023 A | — | 0 | 0 | $0 |
| David A Green | Chief Financial Officer | 21 de Dezembro de 2018 S | 266.250 | 0 | 0 | $0 |
| Gregory A Gould | Chief Financial Officer | 2 de Agosto de 2016 A | 206.899 | 0 | 0 | $0 |
| Christopher Brooke | Chief Operating Officer | 11 de Agosto de 2023 A | — | 0 | 0 | $0 |
| Greg Pyszczymuka | Chief Commercial Officer | 28 de Julho de 2026 A | 56.102 | 0 | 0 | $0 |
| Jarrett Disbrow | Chief Business Officer | 28 de Julho de 2026 A | 76.568 | 0 | 0 | $0 |
| Jonathan H Mcgrael | VP of Commercial Operations | 7 de Julho de 2016 A | 140.000 | 0 | 0 | $0 |
| Abhinav Jain | Conselheiro | 28 de Julho de 2026 A | 29.500 | 0 | 0 | $0 |
| John Donofrio Jr. | Conselheiro | 28 de Julho de 2026 A | 23.762 | 0 | 0 | $0 |
| Carl Dockery | Conselheiro | 28 de Julho de 2026 A | 31.152 | 0 | 0 | $0 |
| Vivian H Liu | Conselheiro | 28 de Julho de 2026 A | 29.825 | 0 | 0 | $0 |
| Gary Cantrell | Conselheiro | 24 de Outubro de 2018 A | 152.840 | 0 | 0 | $0 |
| Michael Macaluso | Conselheiro | 24 de Outubro de 2018 A | 202.738 | 0 | 0 | $0 |
| Ampio Pharmaceuticals, Inc. | Detentor de 10% | 1 de Dezembro de 2015 J | 1.226.407 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 3 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC, Harkey Wilmot B., Mack Daniel ×4 declarações | 9 de Junho de 2025 | 14,40% | Emenda | — | SEC |
| Armistice Capital, LLC, Steven Boyd ×12 declarações | 1 de Setembro de 2021 | — | Declaração inicial | — | SEC |
| AMPIO PHARMACEUTICALS, INC. | 24 de Abril de 2015 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 6 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| DFSU · Dimensional ETF Trust | 0,00% | 4.805 NS | 30 de Abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 2.147 NS | 30 de Abril de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 4.402 NS | 30 de Abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 92.146 SH | 8 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 169.000 SH | 8 de Agosto de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,00% | 4.122 NS | 30 de Abril de 2026 | N-PORT |